MENU

Published on 14/11/2019 9:44:37 AM | Source: Religare Securities Ltd

Option Strategy Glenmark Pharmaceuticals Ltd by Religare Securities

Posted in Broking Firm Views - Short Term Report| #Glenmark Pharmaceuticals Ltd #Pharma Sector #Trading Report #Religare Securities Ltd

Derivative Ideas

GLENMARK added around 11% in open interest as short buildup was seen in it in previous session. Current chart pattern also indicates further down move in its price. We suggest buying GLENMARK 270 PE as per below levels.

Strategy:- BUY GLENMARK 270 PE BETWEEN 8-10, STOPLOSS AT 2, TARGET 20.

 

To Read Complete Report & Disclaimer Click Here

 

For Religare Securities Ltd Disclaimer http://old.religareonline.com/research/Disclaimer/Disclaimer_RSL.html   

 

Above views are of the author and not of the website kindly read disclaimer